Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
Go back to Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.83 -0.19 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.02 | 52 Week High | $3.48 | |||
| Open | $59.56 | 52 Week Low | $0.80 | |||
| Day High | $59.72 | P/E | N/A | |||
| Day Low | $58.51 | EPS | $-1.54 | |||
| Volume | 2,114,331 | |||||
